Real-time enrollment status for this alzheimer's disease clinical trial
Current Status
Recruiting
Checked: March 2, 2026 at 10:16 AM UTC
| NCT Number | NCT06976216 |
| Recruiting Status | Recruiting |
| Condition | Alzheimer's Disease |
| Phase | Clinical Trial |
| Target Enrollment | 586 participants |
| Active Locations | 29 sites in the US |
| Sponsor | Bristol-Myers Squibb |
| Last Updated on CT.gov | February 10, 2026 (2 weeks ago) |
As of March 2, 2026: Clinical trial NCT06976216 is currently recruiting participants. This clinical trial study for alzheimer's disease is actively seeking new participants at 29 locations across the United States. The study is sponsored by Bristol-Myers Squibb. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06976216 is actively recruiting participants as of March 2, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 29 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06976216 was last updated 2 weeks ago (February 10, 2026). HelloStudys verifies this status automatically.